ArticleEBioMedicine2018

Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype.

Mikael Bjursell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.